Skip to main content

Studying the disregulation of protein kinase SLK that leads to glomerulonephritis

Dr. Andrey Cybulsky, M.D.
McGill University
Kidney Health Research Grant
2020 - 2022
$120,000
Glomerulonephritis

Lay Summary

The health of an organism largely depends on the accuracy of signals sent among constituent cells. Much of this information is transmitted inside cells through specific proteins, called protein kinases. Activity of protein kinases contributes to the maintenance of normal cell structure and function, while disorders in protein kinase activation or function can contribute to disease. Diseases of the renal glomerulus (the filtering unit of the kidney), especially those initiated by immunological processes ("glomerulonephritis"), account for approximately half of the causes of chronic kidney disease in Canada. Treatment of patients with kidney disease with dialysis and kidney transplantation has resulted in a dramatic improvement in the survival of patients, but at a large cost to the Canadian economy. Fundamental research into the disordered mechanisms that lead to glomerulonephritis is essential to the understanding of these diseases, an understanding that will ultimately lead to therapy and prevention. 

In this proposal, Dr. Cybulsky will study abnormalities in cellular pathways in the glomerulus involving a protein kinase called SLK, and how disordered regulation of SLK leads to kidney disease. The proposed studies will use a tissue-culture system and animal models of glomerulonephritis to characterize abnormalities contributing to the cause of the disease. The elucidation of basic mechanisms of the causes of disease, and testing of therapies in preclinical (animal) models is likely to be the most productive approach to the development of treatment strategies to human glomerulonephritis. The results of the proposed studies will eventually lead to improved strategies for therapies of kidney disorders.